OUTCOMES OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) FOR ADVANCED PHASES OF CHRONIC MYELOID LEUKEMIA (CML) IN THE EARLY IMATINIB MESYLATE (IM) ERA

被引：0
|
作者：
Khoury, H. J. [1 ]
Kukreja, M. [1 ]
Wang, T. [1 ]
Woolfrey, A. [1 ]
Szer, J. [1 ]
Cortes, J. [1 ]
Horowitz, M. M. [1 ]
Lee, S. [1 ]
机构：
[1] CIBMTR, Milwaukee, WI USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2009年 / 15卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2008.12.178
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
151
引用
收藏
页码：57 / 57
页数：1
相关论文
共 50 条
  • [41] Imatinib mesylate therapy for relapse after allogeneic stem cell transplantation for chronic myelogenous leukemia
    Kantarjian, HM
    O'Brien, S
    Cortes, JE
    Giralt, SA
    Rios, MB
    Shan, JQ
    Giles, FJ
    Thomas, DA
    Faderl, S
    De Lima, M
    Garcia-Manero, G
    Champlin, R
    Arlinghaus, R
    Talpaz, M
    BLOOD, 2002, 100 (05) : 1590 - 1595
  • [42] Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) with a Related Donor in Chronic Myeloid Leukemia (CML): An Explanation for Fast Improvement of Survival in Two Consecutive German CML Studies.
    Pfirrmann, Markus
    Saussele, Susanne
    Leitner, Armin
    Pletsch, Nadine
    Lauseker, Michael
    Mueller, Martin C.
    Haferlach, Claudia
    Schlegelberger, Brigitte
    Schnittger, Susanne
    Ehninger, Gerhard
    Fischer, Thomas
    Hossfeld, Dieter K.
    Kolb, Hans-Jochem
    Krause, Stefan W.
    Nerl, Christoph
    Pralle, Hans
    Tobler, Andreas
    Heimpel, Hermann
    Beelen, Dietrich W.
    Zander, Axel R.
    Bunjes, Donald
    Schrezenmeier, Hubert
    Feldmann, Ulrike
    Mueller, Carlheinz
    Baldomero, Helen
    Schanz, Urs
    Hochhaus, Andreas
    Hasford, Joerg
    Gratwohl, Alois
    Hehlmann, Ruediger
    BLOOD, 2009, 114 (22) : 1270 - 1270
  • [43] Allogeneic myeloablative haematopoietic stem cell transplantation for chronic myeloid leukaemia in the imatinib era
    Pavlu, J.
    Auner, H.
    Szydlo, R.
    Olavarria, E.
    Giles, C.
    Klammer, M.
    Kew, A.
    Milojkovic, D.
    Gabriel, I.
    Rezvani, K.
    Dazzi, F.
    Marin, D.
    Goldman, J.
    Apperley, J.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S49 - S49
  • [44] OUTCOMES AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR PATIENTS WITH ADVANCED CHRONIC LYMPHOCYTIC LEUKEMIA
    Rashed, A.
    Corringham, S.
    Castro, J. E.
    Kipps, T. J.
    Ball, E. D.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S295 - S295
  • [45] Allogeneic hematopoietic stem cell transplantation (HSCT) - EBMT risk score evaluation for chronic myeloid leukemia in Brazil.
    De Souza, C
    Vigorito, AC
    Ruiz, MA
    Nucci, M
    Dulley, FL
    Fincke, VM
    Tabak, D
    Azevedo, AM
    Byington, R
    Macedo, MCM
    Saboya, R
    Aranha, FJP
    Oliveira, GB
    Zulli, R
    Miranda, ECM
    Azevedo, WM
    Lodi, FM
    Voltarelli, JC
    Simoes, BP
    Colturato, V
    De Souza, MP
    Silla, L
    Bittencourt, H
    Ruiz, LP
    Maiolino, A
    Gratwohl, A
    Pasquini, R
    BLOOD, 2004, 104 (11) : 911A - 911A
  • [46] Impact of prior therapy with imatinib mesylate on the outcome of hematopoietic cell transplantation (HCT) for chronic myeloiod leukemia (CML)
    Lee, Stephanie
    Maziarz, Richard
    Kukreja, Manisha
    Wang, Tao
    Giralt, Sergio
    Szer, Jeffrey
    Woolfrey, Ann
    Arora, Mukta
    BLOOD, 2007, 110 (11) : 227A - 227A
  • [47] Imatinib mesylate treatment of patients with chronic myeloid leukaemia relapsing following allogeneic stem cell transplantation
    Conneally, E
    Carroll, P
    Neat, M
    Haslam, K
    Gately, K
    Ryan, J
    Lawler, M
    McCann, S
    BLOOD, 2004, 104 (11) : 248B - 249B
  • [48] Imatinib mesylate for treatment of relapse after allogeneic haematopoietic stem cell transplantation for chronic myeloid leukaemia
    Arqueros, V
    Espigares, A
    Roman, J
    Martin, A
    Jimenez, A
    Fernandez, C
    Capote, M
    Molina, J
    Heiniger, A
    Torres, A
    BONE MARROW TRANSPLANTATION, 2006, 37 : S228 - S228
  • [49] Outcomes of patients with advanced CML treated with allogeneic hematopoietic stem cell transplantation in the Era of tyrosine kinase inhibitors (TKIs)
    Kongtim, P.
    Adekola, K.
    Milton, D.
    Ramlal, R.
    Jimenez, A.
    Chen, J.
    Rondon, G.
    Ahmed, S.
    Betul, O.
    Popat, U.
    Cortes, J.
    Champlin, R.
    Ciurea, S.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S425 - S425
  • [50] Imatinib mesylate for the treatment of relapse of chronic myeloid leukaemia after allogeneic stem cell transplantation.
    Olavarria, E
    Fischer, T
    Ottmann, O
    Clark, R
    Bandini, G
    Byrne, J
    Lipton, J
    Niederwieser, D
    Goldman, J
    BLOOD, 2002, 100 (11) : 329B - 329B
12345